Tuesday, October 29, 2013

Glioblastoma Tumors Helped Without Toxicity

By Robert Sutter

I'm sure that those who are aware of glioblastoma tumors understand that they will be able to grow at different rates. Even though they are viewed as the most serious types out there, you have to keep in mind that no two growths are the same. Methods are going to be created, though, in order to help researchers find answers as well as potential remedies. Is it possible that methods will soon be brought to the surface, this time without the idea of toxicity brought into the picture?

It's important to note that glioblastomas, in general, are seen as the most common and aggressive types of tumors in existence. They are ones that grow at more rapid rates than others, which means that many studies are going to focus on these more so than any others. It's not like work hasn't been done in order to research the matter more, especially when you see articles like the aforementioned story. Of course, you're going to want to pay attention to the most successful of stories out there.

MedPage Today spoke about the matter, saying that the progression of glioblastoma tumors can be changed due to the absence of toxicity. The article said that patients who were part of a particular study received the drug called bevacizumab to start. They were also treated with standard chemoradiation, which is a common method looked at by organizations along the lines of Voices against Brain Cancer. What were the results of this particular study and, just as importantly, did it prove to be useful without having to bring toxicity into account?

You may think that, because it is a drug, bevacizumab is one that shouldn't be used for methods of this nature. In actuality, though, it's pretty common in a number of therapies that have been done in order to help patients with this particular condition. One of the aspects talked about in the article was that it was able to reduce the use of corticosteroids. For those who don't know, these regulate a few different functions, inflammation being one of the most noteworthy to take into account.

To say that this type of research is going to require a tremendous amount of work probably goes without saying. However, there are certain elements that we might have overlooked in the past, toxicity being one of them. Why should something like this be seen at all, especially since there is a chance that researchers and patients alike are not going to be able to benefit from it nearly as much as they should? It's very important to look deeper into researcher to find stronger methods.

About the Author:

No comments:

Post a Comment